VIM and head and neck squamous cell carcinoma: Previous studies have explored the correlation of ZEB2‐AS1 with EMT‐related markers in head and neck squamous cell carcinoma (HNSCC) and triple‐negative BC and showed a positive association between ZEB2‐AS1 and ZEB2/vimentin.